Low & Middle Income Countries Opioid Substitution Therapy Market by Product Type, End-Users, & Geography (North America, Europe, Asia Pacific, Latin America, & MEA): Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2030

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for low and middle income countries opioid substitution therapy. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global low and middle income countries opioid substitution therapy market from 2023 to 2033.

The low and middle income countries opioid substitution therapy market is forecast to expand at a CAGR of 7.2% and thereby increase from a value of US$744.5 Mn in 2023, to US$1,211.2 Mn by the end of 2030.

Key Insights

Low and Middle Income Countries Opioid Substitution Therapy Market Size (2023E): US$744.5 Million

Projected Market Value (2030F): US$1,211.2 Million

Global Market Growth Rate (CAGR 2023 to 2030): 7.2%

Historical Market Growth Rate (CAGR 2018 to 2022): 5.9%

Low and Middle Income Countries Opioid Substitution Therapy Market - Report Scope:

The OST market in LMICs is poised for significant growth, driven by efforts to address the opioid epidemic, reduce substance abuse-related harm, and improve public health outcomes. This market serves healthcare facilities, rehabilitation centers, and community health organizations, offering opioid substitution medications and supportive services. Market growth is fueled by the need for evidence-based addiction treatment, harm reduction strategies, and the expansion of opioid substitution therapy programs in LMICs.

Market Growth Drivers:

The global OST market in LMICs is influenced by several key factors, including the rising prevalence of opioid use disorders, increased awareness of harm reduction strategies, and government initiatives to combat substance abuse. Integration of OST into comprehensive addiction treatment programs, along with the expansion of healthcare infrastructure, contributes to market expansion. Technological innovations in medication formulations and delivery methods further drive market growth. Additionally, collaborations between healthcare providers, non-governmental organizations, and public health agencies play a crucial role in expanding access to OST services.

Market Restraints:

Despite promising growth prospects, the OST market in LMICs faces challenges related to limited resources, stigma associated with addiction, and regulatory hurdles in medication access. Inadequate training for healthcare professionals and insufficient awareness among communities may hinder the effective implementation of OST programs. Economic constraints and competing healthcare priorities pose barriers to scaling up OST services. Overcoming these challenges requires a multi-stakeholder approach, involving governments, international organizations, and civil society, to promote evidence-based addiction treatment and harm reduction strategies.

Market Opportunities:

The OST market in LMICs presents significant growth opportunities driven by ongoing research, policy advocacy, and the evolving landscape of addiction treatment. Implementation of telemedicine and digital health solutions in OST programs, development of cost-effective medication options, and community-based outreach initiatives open new avenues in this market. Strategic partnerships, investment in training programs, and the integration of OST into primary healthcare services are essential for capitalizing on emerging opportunities and sustaining market leadership.

Key Questions Answered in the Report:

What is the Forecast CAGR of the Low and Middle Income Countries Opioid Substitution Therapy Market?

The market is anticipated to grow at a CAGR of 7.2% during the projected period.

What was the Market Size in the Year 2023?
Which Country Held the Largest Market Share in 2023?
Who are the Leading Players in the Low and Middle Income Countries Opioid Substitution Therapy Market?
Which is the Fastest-growing Market Segment in Terms of the Distribution Channel?

Competitive Intelligence and Business Strategy:

Leading players in the global OST market within LMICs, including [Insert Key Organizations], focus on collaboration, capacity building, and strategic partnerships to address the unique challenges of addiction treatment in resource-constrained settings. These organizations invest in research and development to adapt evidence-based practices to local contexts, ensuring the effectiveness and feasibility of OST programs. Collaborations with governments, international agencies, and local NGOs facilitate program implementation and advocacy for policy reforms. Moreover, community engagement, training for healthcare providers, and continuous monitoring and evaluation contribute to the success of OST initiatives in LMICs.

Key Organizations Profiled:
Indivior Inc.
Alkermes, Inc
Mundipharma GmbH
Viatris Inc
Intas Pharmaceuticals
Camurus

Low and Middle Income Countries Opioid Substitution Therapy Market Research Segmentation

The opioid agonists, particularly methadone and buprenorphine, dominate the LMICs opioid substitution therapy market due to their comprehensive approach in addressing opioid dependence. Opioid antagonists, such as naloxone and naltrexone, are the fastest-growing category, responding to emergency situations like opioid overdoses.

Opioid withdrawal/opioid use disorder (OUD) is the dominant indication, driven by escalating public health concerns related to opioid misuse. Pain management is the fastest-growing category, fueled by the expanding clinical applications of opioid substitution therapies.

Government-supported centers, NGO initiatives, and tenders are the leading distribution channels, ensuring widespread availability of opioid substitution therapies. Online sales emerge as the fastest-growing channel, driven by technological advancements and increased access to telehealth platforms.

In regional markets, Europe dominates the LMICs opioid substitution therapy market, driven by a progressive approach to harm reduction and comprehensive healthcare systems. The region's commitment to evidence-based interventions and strategic policies positions it as a leader in addressing opioid dependence in LMICs.

By Drug Class:
Opioid Antagonists
Naloxone
Naltrexone

Opioid Agonists and Partial Agonists

Methadone
Buprenorphine
By Indication:
Pain Management

Opioid Withdrawal/Opioid Use Disorder (OUD)

Alcohol De-addiction
Depression
By Distribution Channel:

Government-supported Centers/NGO's/Tenders

Institutional Sales
Hospitals
Psychiatric clinics
Retail Pharmacies
Online Sales
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33745

1. Executive Summary

1.1. Global Low and Middle Income Countries Opioid Substitution Therapy Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Drug Class Lifecycle Analysis
2.4. Low and Middle Income Countries Opioid Substitution Therapy Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Drug Class
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug Class, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
  - 3.3.3.1. Opioid Antagonists
  - 3.3.3.2. Naloxone
  - 3.3.3.3. Naltrexone
  - 3.3.3.4. Opioid Agonists and Partial Agonists
  - 3.3.3.5. Methadone
  - 3.3.3.6. Buprenorphine
3.4. Market Attractiveness Analysis: Drug Class
3.5. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Indication
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
  - 3.5.3.1. Pain Management
  - 3.5.3.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
  - 3.5.3.3. Alcohol De-addiction
  - 3.5.3.4. Depression
3.6. Market Attractiveness Analysis: Indication
3.7. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Distribution Channel
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
  - 3.7.3.1. Government-supported Centers/NGO's/Tenders
  - 3.7.3.2. Institutional Sales
  - 3.7.3.3. Hospitals
  - 3.7.3.4. Psychiatric clinics
  - 3.7.3.5. Retail Pharmacies
  - 3.7.3.6. Online Sales
3.8. Market Attractiveness Analysis: Distribution Channel

4. Global Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia & Pacific
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Drug Class
- 5.3.3. By Indication
- 5.3.4. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
- 5.5.1. Opioid Antagonists
- 5.5.2. Naloxone
- 5.5.3. Naltrexone
- 5.5.4. Opioid Agonists and Partial Agonists
- 5.5.5. Methadone
- 5.5.6. Buprenorphine
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
- 5.6.1. Pain Management
- 5.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
- 5.6.3. Alcohol De-addiction
- 5.6.4. Depression
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 5.7.1. Government-supported Centers/NGO's/Tenders
- 5.7.2. Institutional sales
- 5.7.3. Hospitals
- 5.7.4. Psychiatric clinics
- 5.7.5. Retail Pharmacies
- 5.7.6. Online Sales
5.8. Market Attractiveness Analysis

6. Europe Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Drug Class
- 6.3.3. By Indication
- 6.3.4. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
- 6.5.1. Opioid Antagonists
- 6.5.2. Naloxone
- 6.5.3. Naltrexone
- 6.5.4. Opioid Agonists and Partial Agonists
- 6.5.5. Methadone
- 6.5.6. Buprenorphine
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
- 6.6.1. Pain Management
- 6.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
- 6.6.3. Alcohol De-addiction
- 6.6.4. Depression
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 6.7.1. Government-supported Centers/NGO's/Tenders
- 6.7.2. Institutional sales
- 6.7.3. Hospitals
- 6.7.4. Psychiatric clinics
- 6.7.5. Retail Pharmacies
- 6.7.6. Online Sales
6.8. Market Attractiveness Analysis

7. East Asia Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Drug Class
- 7.3.3. By Indication
- 7.3.4. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
- 7.5.1. Opioid Antagonists
- 7.5.2. Naloxone
- 7.5.3. Naltrexone
- 7.5.4. Opioid Agonists and Partial Agonists
- 7.5.5. Methadone
- 7.5.6. Buprenorphine
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
- 7.6.1. Pain Management
- 7.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
- 7.6.3. Alcohol De-addiction
- 7.6.4. Depression
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 7.7.1. Government-supported Centers/NGO's/Tenders
- 7.7.2. Institutional sales
- 7.7.3. Hospitals
- 7.7.4. Psychiatric clinics
- 7.7.5. Retail Pharmacies
- 7.7.6. Online Sales
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Drug Class
- 8.3.3. By Indication
- 8.3.4. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
- 8.5.1. Opioid Antagonists
- 8.5.2. Naloxone
- 8.5.3. Naltrexone
- 8.5.4. Opioid Agonists and Partial Agonists
- 8.5.5. Methadone
- 8.5.6. Buprenorphine
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
- 8.6.1. Pain Management
- 8.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
- 8.6.3. Alcohol De-addiction
- 8.6.4. Depression
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 8.7.1. Government-supported Centers/NGO's/Tenders
- 8.7.2. Institutional sales
- 8.7.3. Hospitals
- 8.7.4. Psychiatric clinics
- 8.7.5. Retail Pharmacies
- 8.7.6. Online Sales
8.8. Market Attractiveness Analysis

9. Latin America Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Drug Class
- 9.3.3. By Indication
- 9.3.4. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
- 9.5.1. Opioid Antagonists
- 9.5.2. Naloxone
- 9.5.3. Naltrexone
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
- 9.6.1. Pain Management
- 9.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
- 9.6.3. Alcohol De-addiction
- 9.6.4. Depression
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 9.7.1. Government-supported Centers/NGO's/Tenders
- 9.7.2. Institutional sales
- 9.7.3. Hospitals
- 9.7.4. Psychiatric clinics
- 9.7.5. Retail Pharmacies
- 9.7.6. Online Sales
9.8. Market Attractiveness Analysis

10. Middle East & Africa Low and Middle Income Countries Opioid Substitution Therapy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Drug Class
- 10.3.3. By Indication
- 10.3.4. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
- 10.5.1. Opioid Antagonists
- 10.5.2. Naloxone
- 10.5.3. Naltrexone
- 10.5.4. Opioid Agonists and Partial Agonists
- 10.5.5. Methadone
- 10.5.6. Buprenorphine
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
- 10.6.1. Pain Management
- 10.6.2. Opioid Withdrawal/Opioid Use Disorder (OUD)
- 10.6.3. Alcohol De-addiction
- 10.6.4. Depression
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 10.7.1. Government-supported Centers/NGO's/Tenders
- 10.7.2. Institutional sales
- 10.7.3. Hospitals
- 10.7.4. Psychiatric clinics
- 10.7.5. Retail Pharmacies
- 10.7.6. Online Sales
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Dashboard
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Indivior Inc.
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Alkermes, Inc
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Mundipharma GmbH
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Viatris Inc
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Intas Pharmaceuticals
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Camurus
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations